Cargando…

Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction

Glioblastoma represents the most devastating form of human brain cancer, associated with a very poor survival rate of patients. Unfortunately, treatment options are currently limited and the gold standard pharmacological treatment with the chemotherapeutic drug temozolomide only slightly increases t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dahlmanns, Marc, Yakubov, Eduard, Dahlmanns, Jana Katharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671613/ https://www.ncbi.nlm.nih.gov/pubmed/34926298 http://dx.doi.org/10.3389/fonc.2021.783067

Ejemplares similares

Ferroptosis and PPAR-gamma in the limelight of brain tumors and edema
por: Yakubov, Eduard, et al.
Publicado: (2023)

Editorial: Ferroptosis in malignant brain tumors
por: Yakubov, Eduard, et al.
Publicado: (2023)

Iron Transporters and Ferroptosis in Malignant Brain Tumors
por: Zhao, Jingyu, et al.
Publicado: (2022)

Ferroptosis in hematological malignant tumors
por: Liu, Yong, et al.
Publicado: (2023)

Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool
por: Dahlmanns, Marc, et al.
Publicado: (2017)

Pharmacological targets for the induction of ferroptosis: Focus on Neuroblastoma and Glioblastoma
por: Ferrada, Luciano, et al.
Publicado: (2022)

Common network effect-patterns after monoamine reuptake inhibition in dissociated hippocampus cultures
por: Trepl, Julia, et al.
Publicado: (2022)

Correction to: Common network effect‑patterns after monoamine reuptake inhibition in dissociated hippocampus cultures
por: Trepl, Julia, et al.
Publicado: (2022)

Tonic activin signaling shapes cellular and synaptic properties of CA1 neurons mainly in dorsal hippocampus
por: Dahlmanns, Marc, et al.
Publicado: (2023)

Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy
por: Sun, Yonghao, et al.
Publicado: (2022)

Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications
por: Yu, Jie, et al.
Publicado: (2021)

Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies
por: Zhao, Yan, et al.
Publicado: (2021)

Solasonine Inhibits Pancreatic Cancer Progression With Involvement of Ferroptosis Induction
por: Liang, Xiaoqiang, et al.
Publicado: (2022)

Effect of tumor microenvironment on ferroptosis: inhibition or promotion
por: Xia, Zhengzhen, et al.
Publicado: (2023)

Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors
por: Cai, Huazhong, et al.
Publicado: (2023)

Induction of Ferroptosis by Ophiopogonin-B Through Regulating the Gene Signature AURKA in NSCLC
por: Li, Liqiu, et al.
Publicado: (2022)

Ferroptosis-Mediated Formation of Tumor-Promoting Immune Microenvironment
por: Bi, Qing, et al.
Publicado: (2022)

Ferroptosis-based drug delivery system as a new therapeutic opportunity for brain tumors
por: Yao, Yansheng, et al.
Publicado: (2023)

Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer
por: Wang, Hong-Tao, et al.
Publicado: (2022)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020)

Ferroptosis: Biochemistry and Biology in Cancers
por: Shi, Zhiyuan, et al.
Publicado: (2021)

Emerging roles of ferroptosis in glioma
por: Shi, Jiaqi, et al.
Publicado: (2022)

The role of Hippo pathway in ferroptosis
por: Xiang, Jiangxia, et al.
Publicado: (2023)

Microenvironment immune response induced by tumor ferroptosis—the application of nanomedicine
por: Yun, Tian, et al.
Publicado: (2022)

Targeted p53 on Small-Molecules-Induced Ferroptosis in Cancers
por: Zhang, Weifen, et al.
Publicado: (2018)

Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022)

Mesothelioma Driver Genes, Ferroptosis, and Therapy
por: Felley-Bosco, Emanuela, et al.
Publicado: (2019)

Ferroptosis: Redox Imbalance and Hematological Tumorigenesis
por: Lan, Hongying, et al.
Publicado: (2022)

Ferroptosis in osteosarcoma: A promising future
por: Liu, Xiang, et al.
Publicado: (2022)

Ferroptosis in Cancer Treatment: Another Way to Rome
por: Wu, Yinan, et al.
Publicado: (2020)

Ferroptosis: A New Strategy for Cancer Therapy
por: Chen, Yu, et al.
Publicado: (2022)

Novel Therapeutic Savior for Osteosarcoma: The Endorsement of Ferroptosis
por: Qiu, Cheng, et al.
Publicado: (2022)

Potential Role of APEX1 During Ferroptosis
por: Guo, Nan, et al.
Publicado: (2022)

Ferroptosis in Glioma Immune Microenvironment: Opportunity and Challenge
por: Wang, Kaikai, et al.
Publicado: (2022)

Opportunities and challenges related to ferroptosis in glioma and neuroblastoma
por: Chi, Huizhong, et al.
Publicado: (2023)

The potential of ferroptosis combined with radiotherapy in cancer treatment
por: Lu, Zekun, et al.
Publicado: (2023)

Lipid droplets and ferroptosis as new players in brain cancer glioblastoma progression and therapeutic resistance
por: Bezawork-Geleta, Ayenachew, et al.
Publicado: (2022)

Roles of ferroptosis in urologic malignancies
por: Zhao, Shankun, et al.
Publicado: (2021)

Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment
por: Zhu, Jingjuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fhgl9trrf56mjdcu2r15vqpv7u